This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Pharmala Biotech Inc.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Harpreet Kaur: Innovator in Pharmaceutical Chemistry
Introduction
Harpreet Kaur is a notable inventor based in Colwood, Canada. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of enantiomerically pure compounds. Her work focuses on innovative solutions for treating various diseases and disorders.
Latest Patents
Harpreet Kaur holds a patent for the compound (R)-2-[(2H-1,3-benzodioxol-5-yl)methyl]pyrrolidine and its associated processes, compositions, and uses. This patent includes an enantiomerically pure compound of Formula (R)-I, which can be utilized in treating conditions that benefit from psychotherapy. The patent also covers compositions that include a non-racemic mixture of the compound and methods for preparing these compounds.
Career Highlights
Harpreet Kaur is currently associated with Pharmala Biotech Inc., where she continues to advance her research and development efforts. Her innovative approach has positioned her as a key player in the pharmaceutical industry, contributing to the advancement of therapeutic options.
Conclusion
Harpreet Kaur's work exemplifies the impact of innovation in pharmaceutical chemistry. Her patent and ongoing research reflect her commitment to improving treatment methodologies for various health conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile